Life-Altering Shift for Wiltshire Woman with Sleep Apnoea
I dreaded bedtime before new sleep – For years, Catherine Turnbull of Chippenham dreaded bedtime, as the night-time struggles of sleep apnoea left her gasping for air and exhausted by dawn. Her experience with the condition, which she had long struggled to manage, was transformed by a groundbreaking new sleep apnoea treatment—hypoglossal nerve stimulation (HGNS)—now available at Swindon’s Great Western Hospital (GWH). This innovative therapy, which targets the root cause of the disorder, has not only restored her ability to sleep deeply but also redefined her quality of life. As someone who once found bedtime a source of dread, Turnbull’s journey from sleepless nights to restful slumber offers a compelling glimpse into the potential of modern medical advancements.
A Breakthrough in Sleep Therapy
The HGNS treatment works by stimulating the hypoglossal nerve, which controls tongue movement, to prevent airway blockages during sleep. This method, distinct from traditional continuous positive airway pressure (CPAP) machines, has been a game-changer for patients like Turnbull, who found CPAP cumbersome and uncomfortable. Unlike the bulky masks associated with CPAP, the HGNS device involves a small generator implanted in the chest and a lead connected to the nerve. Each night, a remote control—a device similar to a computer mouse—activates the treatment, making it seamless and discreet. This approach, part of a limited rollout across five NHS trusts in the UK, is now helping patients who have long suffered from sleep apnoea reclaim their nights.
“I used to wake up in the middle of the night, gasping for air, and felt like I was suffocating,” Turnbull explained. “The new sleep apnoea treatment has changed everything. I can’t wait to go to bed now—it’s like breathing again for the first time.”
Understanding the Condition and Its Impact
Sleep apnoea is a serious disorder that affects millions globally, with symptoms often going unnoticed or misdiagnosed. For women, the condition can be particularly challenging, as signs like night-time awakenings and fatigue are sometimes attributed to menopause or stress. Turnbull’s experience highlights the profound toll of untreated sleep apnoea, which can lead to severe exhaustion, difficulty concentrating, and even increased risks of cardiovascular issues. According to NHS guidelines, breathing pauses can occur more than 100 times per hour, disrupting sleep and affecting daily functioning. The introduction of HGNS represents a significant step forward in addressing these challenges, especially for those who find CPAP difficult to adapt to.
The procedure itself is minimally invasive, involving a small incision and the implantation of a generator. Patients are typically candidates for HGNS if they have moderate to severe obstructive sleep apnoea and have failed to respond to CPAP. Dr. Joseph Sinnott, an ear, nose, and throat surgeon at GWH, emphasized that the treatment offers a long-term solution for patients who have struggled with traditional methods. “For some individuals, the new sleep apnoea treatment is a life-changing alternative,” he said. “It’s not just about getting through the night—it’s about regaining control of your health.”
Transforming Lives: A Patient’s Perspective
Turnbull’s story is not unique. Many people living with sleep apnoea report similar struggles, often feeling trapped by their own bodies. Before the new sleep apnoea treatment, she described her sleep as “a constant battle,” with frequent awakenings and a lingering sense of panic. Now, she wakes up refreshed and energized, a stark contrast to the exhaustion that once defined her days. “The new sleep apnoea treatment has given me back my life,” she said. “I used to dread bedtime, but now I’m looking forward to it.”
As the treatment gains traction, more patients are beginning to see the benefits. With approximately 125,000 procedures performed worldwide, HGNS is becoming an increasingly accessible option. Turnbull hopes her journey will inspire others to seek treatment, particularly those who have felt frustrated by the limitations of CPAP. “It’s amazing how the new sleep apnoea treatment can turn things around,” she added. “I’ve not only improved my sleep but also my confidence and overall well-being.”
The Future of Sleep Apnoea Care
While CPAP remains the gold standard for treating sleep apnoea, HGNS is expanding the range of options available to patients. This treatment is particularly beneficial for those who experience discomfort from masks or find it hard to maintain consistent use. The device’s ability to stimulate the tongue without the need for continuous airflow makes it a more comfortable alternative. As NHS trusts continue to adopt HGNS, the potential for improving sleep health and reducing long-term complications is growing. For patients like Turnbull, the new sleep apnoea treatment is a beacon of hope, offering a path to restful sleep and a renewed sense of vitality.
“I dreaded bedtime before the new sleep apnoea treatment, but now I feel like I’ve been given a second chance at sleep,” Turnbull reflected. “It’s not just about the night—it’s about the morning, about living fully.”
